Search and Filter
Results per Page:
Dr. Keith Jerome on herpes research, cure efforts and the future of virology
Oncology Insights with Dr. Petros Grivas - Episode 23
HSV and cancer: What patients should know
Cancer treatments can weaken immunity and trigger herpes simplex reactivation, but patients can take protective steps
Fred Hutch researchers look at longevity in older women, metabolic signatures of vaginitis
Two prestigious R01 NIH grants awarded to Drs. Alex Reiner, Sujatha Srinivasan
ASCO Young Investigator Award winners showcase the breadth and depth of Fred Hutch research
Hematology-oncology fellows and faculty receive $50,000 each toward early-career projects
Dr. Hans-Peter Kiem receives ASGCT mentorship award
Fred Hutch gene therapy expert views mentorship as a lifelong commitment
Two Fred Hutch students receive American Society for Hematology graduate awards
The two-year, $40,000 annual awards support emerging researchers studying myelodysplastic syndromes and pediatric leukemia
The benefits of HIV research? Let us count the ways
HIV work has helped shape the FDA, provided drugs for other infections, changed health systems globally and more, say Fred Hutch experts
Scientists see foam as starting point of a path to bedside gene therapy
Bioengineer Dr. Matthias Stephan developed a quick-foaming solution that he hopes could one day turn gene therapy into an outpatient procedure
New horizons in infectious disease treatment and prevention in immunocompromised patients
The 5th Symposium on Infectious Disease in the Immunocompromised Host emphasized new opportunities, next generation
American Society of Clinical Oncology honors Fred Hutch and UW hematology-oncology fellows
Five early-career researchers to each receive $50,000 toward innovative cancer research projects
Gene therapy delivery system successfully targets CD90+ hematopoietic stem cells in vivo
Fred Hutch laboratory research presented at the American Society of Gene and Cell Therapy’s annual meeting moves a promising approach one step closer to clinical trials
Drs. Keith Jerome and Jesse Bloom elected fellows of American Academy of Microbiology
Fred Hutch researchers’ study of viruses evolves from basic understanding to practical applications
With respiratory infections rampant, experts urge masking and vaccination
Limited disease data makes it hard to accurately assess flu trends
Starting the year smarter
How patients, providers, researchers and others stay informed amid a deluge of data and information
Laying the groundwork for a new cancer-preventive vaccine
Fred Hutch scientists garner large NCI award to uncover secrets of immune response to virus behind Kaposi sarcoma
Infectious disease experts propose trials network dedicated to immunocompromised patients
ImmunOptimize workshop convened stakeholders across disciplines to brainstorm infectious disease clinical trials network designed to serve people with weakened immune systems
Engineered HSV can trigger genetic chain reaction, rejigger HSV genes during co-infection
Proof-of-concept work raises hope that ‘gene drive’ could one day form basis of curative gene therapy for herpes
Zeroing in on vaginal microbes that most increase HIV risk
Signature combination of BV bacteria and immune proteins associated with highest risk could help guide prevention
$5.25M from the Kuni Foundation propels innovative adult oncology research
Grants will support research on tumor regression, immunotherapy access and better care for breast, liver and peritoneal malignancies
Fred Hutch and UW hematology-oncology fellows win ASCO Young Investigator Awards
Winners represent broad range of research